Chemistry: molecular biology and microbiology – Treatment of micro-organisms or enzymes with electrical or... – Modification of viruses
Reexamination Certificate
2006-09-19
2006-09-19
Graser, Jennifer E. (Department: 1645)
Chemistry: molecular biology and microbiology
Treatment of micro-organisms or enzymes with electrical or...
Modification of viruses
C424S244100, C424S185100, C424S190100
Reexamination Certificate
active
07109006
ABSTRACT:
The invention relates to the field of diagnosis of and vaccination against Streptococcal infections and to the detection of virulence markers of Streptococci. The invention discloses a method for modulating virulence of aStreptococcuscomprising modifying a genomic fragment ofStreptococcuswherein the genomic fragment comprises at least a functional part of a fragment identifiable by hybridization inStreptococcus suisto a nucleic acid or fragment thereof as shown inFIG. 5.
REFERENCES:
patent: 5610011 (1997-03-01), Smith et al.
patent: 5681570 (1997-10-01), Yang et al.
patent: 5733765 (1998-03-01), Mollet et al.
patent: 5786184 (1998-07-01), Mollet et al.
patent: 5928900 (1999-07-01), Masure et al.
patent: 5948900 (1999-09-01), Yother et al.
patent: 5981229 (1999-11-01), Masure et al.
patent: 2002/0055168 (2002-05-01), Smith
patent: 0 750 043 (2001-05-01), None
patent: WO 92/16630 (1992-10-01), None
patent: WO 95/06732 (1995-03-01), None
patent: WO 95/31548 (1995-11-01), None
patent: WO 96/21465 (1996-07-01), None
patent: WO 00/05378 (2000-02-01), None
patent: WO 02/038597 (2002-05-01), None
patent: WO 02/061070 (2002-08-01), None
Smith et al. Submitted. Sep. 20, 2000. Accession No. AF306940.
Smith et al (Infect. Immun. Mar. 2001. 69(3): 1961-66).
Allgaier et al., Relatedness ofStreptococcus suisisolates of various serotypes and clinical backgrounds as evaluated by macrorestriction analysis and expression of potential virulence traits. Journal of Clinical Microbiology, 2001, pp. 445-453, vol. 39, No. 2.
Busque et al., Immunization of pigs againstStreptococcus suisserotype 2 infection using a live avirulent strain, Can J Vet Res., Oct. 1997, pp. 275-279, vol. 61, No. 4.
Charland et al.,Streptococcus suisserotype 2 mutants deficient in capsular expression, Microbiology, Feb. 1998, pp. 325-332, vol. 144, No. 2.
Elliott et al., Streptococcal infection in young pigs. V. An immunogenic polysaccharide fromStreptoccoccus suistype 2 with particular reference to vaccination against streptococcal meningitis in pigs, Oct. 1980, pp. 275-285, vol. 85, No. 2.
Kolkman et al., Diversity of capsular polysaccharide synthesis gene clusters inStreptococcus pneumoniae, J. Biochem., May 1998, pp. 937-945, vol. 123, No. 5.
Quessy et al., Immunization of mice againstStreptococcus suisserotype 2 infections using a live avirulent strain, Can J. Vet Res., Oct. 1994, pp. 299-301, vol. 58, No. 4.
Roberts et al., The biochemistry and genetics of capsular polysaccharide production in bacteria, Ann. Rev. Microbiol., 1996, pp. 285-315, vol. 50.
Smith et al., High efficiency transformation and gene inactivation inStreptococcus suistype 2, Microbiology, Jan. 1995, pp. 181-188, vol. 141.
Smith et al., Identification and characterization of the cps locus ofStreptococcus suisserotype 2: the capsule protects against phagocytosis and is an important virulence factor, Infect Immun., Apr. 1999, pp. 1750-1756, vol. 67, No. 4.
Smith et al., Cloning and nucleotide sequence of the gene encoding the 136-kilodalton surface protein (muramidase-released protein) ofStreptococcus suistype 2, Infection and Immunity, 1992, pp. 2361-2367, vol. 60, No. 6.
Smith et al., Repeats in an extracellular protein of weakly pathogenic strains ofStreptococcus suistype 2 are absent in pathogenic strains, Infection and Immunity, 1993, pp. 3318-3326, vol. 61, No. 8.
Smith et al., The cps locus ofStreptococcus suisserotype 2: genetic determinant for the synthesis of sialic acid, Microbial Pathogenesis, 2000, pp. 127-134, vol. 29, No. 2.
Smith et al., Selection of virulence-associated determinants ofStreptococcus suisserotype 2 by in vivo complementation, Infection and Immunity, Mar. 2001, pp. 1961-1966, vol. 69, No. 3.
PCT International Search Report, PCT/NL01/00805, dated Jun. 6, 2002, 3 pages.
PCT International Preliminary Examination Report, PCT/NL01/00805, dated Sep. 8, 2002, 2 pages.
Watson et al., Pneumococcal Virulence Factors and Host Immune Responses to Them, European Journal of Clinical Microbiology & Infectious Diseases, Jun. 1995, pp. 479-490, vol. 14, No. 6.
DATABASE EMBL ‘Online’ McNab, S. gordonii partial aldB gene, cshA gene & fbpA gene, Database accession No. X65164, XP002213089.
De Greeff et al., Contribution of Fibronectin-Binding Protein to Pathogenesis ofStreptococcus suisSerotype 2, Infection and Immunity, Mar. 2002, pp. 1319-1325, vol. 70, No. 3.
De Greeff et al., Distribution of Environmentally Regulated Genes ofStreptococcus suisSerotype 2 amongS. suisSerotypes and Other Organisms, Journal of Clinical Microbiology, Sep. 2002, pp. 3261-3268, vol. 40, No. 9.
Kawabata et al., Molecular cloning, sequence and characterization of a novel streptococcal phosphoglycerate dehydrogenase gene, Oral Microbiology and Immunology, 2000, pp. 58-62, vol. 15.
Koskiniemi et al., Identification of two genes, cpsX and cpxY, with putative regulatory function on capsule expression in group B streptococci, FEMS Immunology and Medical Microbiology, 1998, pp. 159-168, vol. 21.
McNab, Cloning and sequence analysis of thymidine kinase from the oral bacteriumStreptococcus gordonii, FEMS Microbiology Letters, 1996, pp. 103-110, vol. 135.
Munoz et al., Characterization of IS1515, a Functional Insertion Sequence inStreptococcus pneumoniae, Journal of Bacteriology, Mar. 1998, pp. 1381-1388, vol. 180, No. 6.
Segers et al., Characterisation of the gene encoding suilysin fromStreptococcus suisand expression in fields strains, FEMS Microbiology Letters, 1998, pp. 255-261, vol. 167.
Smith et al., Environmentally regulated genes ofStreptococcus suis: identification by the use of iron-restricted conditions in vitro and by experimental infections of piglets, Microbiology, 2001, pp. 271-280, vol. 147.
Smith et al., Mutants ofStreptococcus suisTypes 1 and 2 Impaired in Expression of Muramidase-Released Protein and Extracellular Protein Induce Disease in Newborn Germfree Pigs, Infection and Immunity, Oct. 1996, pp. 4409-4412, vol. 64, No. 10.
Graser Jennifer E.
ID-Lelystad, Instituut Voor Dierhouderij en Diergezondheid B.V.
TraskBritt
LandOfFree
Virulence of Streptococci does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Virulence of Streptococci, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Virulence of Streptococci will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3554997